Presynaptic Dysfunction by Familial Factors in Parkinson Disease
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Parkinson disease (PD) is the second most prevalent neurodegenerative disorder after Alzheimer disease. The loss of specific brain area, the substantia nigra pars compacta is known as a major etiology, however it is not fully understood how this neurodegeneration is initiated and what precisely causes this disease. As one aspect of pathophysiology for PD, synaptic dysfunction (synaptopathy) is thought to be an earlier appearance for neurodegeneration. In addition, some of the familial factors cumulatively exhibit that these factors such as α-synuclein, leucine-rich repeat kinase 2, parkin, PTEN-induced kinase 1, and DJ-1 are involved in the regulation of synaptic function and missense mutants of familial factors found in PD-patient show dysregulation of synaptic functions. In this review, we have discussed the physiological function of these genetic factors in presynaptic terminal and how dysregulation of presynaptic function by genetic factors might be related to the pathogenesis of Parkinson disease.
Abstract
Parkinson disease (PD) is the second most prevalent neurodegenerative disorder after Alzheimer disease. The loss of specific brain area, the substantia nigra pars compacta is known as a major etiology, however it is not fully understood how this neurodegeneration is initiated and what precisely causes this disease. As one aspect of pathophysiology for PD, synaptic dysfunction (synaptopathy) is thought to be an earlier appearance for neurodegeneration. In addition, some of the familial factors cumulatively exhibit that these factors such as α-synuclein, leucine-rich repeat kinase 2, parkin, PTEN-induced kinase 1, and DJ-1 are involved in the regulation of synaptic function and missense mutants of familial factors found in PD-patient show dysregulation of synaptic functions. In this review, we have discussed the physiological function of these genetic factors in presynaptic terminal and how dysregulation of presynaptic function by genetic factors might be related to the pathogenesis of Parkinson disease.
참고문헌 (61)
- Klein C, "Genetics of Parkinson’s disease", Cold Spring Harb Perspect Med, 2, pp.a008888~ (2012)
- Jakes R, "Identification of two distinct synucleins from human brain", FEBS Lett, 345, pp.27~32 (1994)
- Shen J, "Protein kinases linked to the pathogenesis of Parkinson’s disease", Neuron, 44, pp.575~577 (2004)
- Zimprich A, "Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology", Neuron, 44, pp.601~607 (2004)
- Paisan-Ruiz C, "Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease", Neuron, 44, pp.595~600 (2004)
- Kitada T, "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism", Nature, 392, pp.605~608 (1998)
- Valente EM, "Hereditary early-onset Parkinson’s disease caused by mutations in PINK1", Science, 304, pp.1158~1160 (2004)
- Schirinzi T, "Early synaptic dysfunction in Parkinson’s disease: insights from animal models", Mov Disord, 31, pp.802~813 (2016)
- Phan JA, "Early synaptic dysfunction induced by alpha-synuclein in a rat model of Parkinson’s disease", Sci Rep, 7, pp.6363~ (2017)
- Nemani VM, "Increased expression of α-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis", Neuron, 65, pp.66~79 (2010)
- Bendor JT, "The function of α-synuclein", Neuron, 79, pp.1044~1066 (2013)
- Hunn BH, "Impaired intracellular trafficking defines early Parkinson’s disease", Trends Neurosci, 38, pp.178~188 (2015)
- Vargas KJ, "Synucleins regulate the kinetics of synaptic vesicle endocytosis", J Neurosci, 34, pp.9364~9376 (2014)
- Matta S, "LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis", Neuron, 75, pp.1008~1021 (2012)
- Ambroso MR, "Endophilin A1 induces different membrane shapes using a conformational switch that is regulated by phosphorylation", Proc Natl Acad Sci U S A, 111, pp.6982~6987 (2014)
- Bottner M, "Alpha-synuclein is associated with the synaptic vesicle apparatus in the human and rat enteric nervous system", Brain Res, 1614, pp.51~59 (2015)
- Bellani S, "The regulation of synaptic function by α-synuclein", Commun Integr Biol, 3, pp.106~109 (2010)
- Lundblad M, "Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons", Proc Natl Acad Sci U S A, 109, pp.3213~3219 (2012)
- Janezic S, "Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model", Proc Natl Acad Sci U S A, 110, pp.E4016~E4025 (2013)
- Hassink GC, "Exogenous α-synuclein hinders synaptic communication in cultured cortical primary rat neurons", PLoS One, 13, pp.e0193763~ (2018)
- Larsen KE, "α-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis", J Neurosci, 26, pp.11915~11922 (2006)
- Lai Y, "Nonaggregated alpha-synuclein influences SNARE-dependent vesicle docking via membrane binding", Biochemistry, 53, pp.3889~3896 (2014)
- Breda C, "Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour", Hum Mol Genet, 24, pp.1077~1091 (2015)
- Logan T, "α-Synuclein promotes dilation of the exocytotic fusion pore", Nat Neurosci, 20, pp.681~689 (2017)
- Xu J, "α-Synuclein mutation inhibits endocytosis at mammalian central nerve terminals", J Neurosci, 36, pp.4408~4414 (2016)
- Ben Gedalya T, "α-Synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling", Traffic, 10, pp.218~234 (2009)
- Eguchi K, "Wild-type monomeric α-synuclein can impair vesicle endocytosis and synaptic fidelity via tubulin polymerization at the calyx of held", J Neurosci, 37, pp.6043~6052 (2017)
- Vargas KJ, "Synucleins have multiple effects on presynaptic architecture", Cell Rep, 18, pp.161~173 (2017)
- Takamori S, "Molecular anatomy of a trafficking organelle", Cell, 127, pp.831~846 (2006)
- Volta M, "Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice", Elife, 6, pp.e28377~ (2017)
- Tozzi A, "Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson’s disease", Neurobiol Dis, 118, pp.1~8 (2018)
- Sweet ES, "The Parkinson’s disease-associated mutation LRRK2-G2019S impairs synaptic plasticity in mouse hippocampus", J Neurosci, 35, pp.11190~11195 (2015)
- Beccano-Kelly DA, "Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice", Front Cell Neurosci, 8, pp.301~ (2014)
- Tong Y, "R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice", Proc Natl Acad Sci U S A, 106, pp.14622~14627 (2009)
- Shin N, "LRRK2regulates synaptic vesicle endocytosis", Exp Cell Res, 314, pp.2055~2065 (2008)
- Arranz AM, "LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism", J Cell Sci, 128, pp.541~552 (2015)
- Maas JW, "Endogenous leucine-rich repeat kinase 2 slows synaptic vesicle recycling in striatal neurons", Front Synaptic Neurosci, 9, pp.5~ (2017)
- Pan PY, "Parkinson’s disease-associated LRRK2 hyperactive kinase mutant disrupts synaptic vesicle trafficking in ventral midbrain neurons", J Neurosci, 37, pp.11366~11376 (2017)
- Soukup SF, "A LRRK2-dependent endophilinA phosphoswitch is critical for macroautophagy at presynaptic terminals", Neuron, 92, pp.829~844 (2016)
- Soukup SF, "EndoA", Endophilin-A creates docking stations for autophagic proteins at synapses, 2017, pp.13, 971~972
- Zhang Y, "Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1", Proc Natl Acad Sci U S A, 97, pp.13354~13359 (2000)
- Oyama G, "Impaired in vivo dopamine release in parkin knockout mice", Brain Res, 1352, pp.214~222 (2010)
- Cortese GP, "Parkin deficiency reduces hippocampal glutamatergic neurotransmission by impairing AMPA receptor endocytosis", J Neurosci, 36, pp.12243~12258 (2016)
- Jiang H, "Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells", Nat Commun, 3, pp.668~ (2012)
- Cao M, "Upregulation of Parkin in endophilin mutant mice", J Neurosci, 34, pp.16544~16549 (2014)
- Pearlstein E, "Abnormal development of glutamatergic synapses afferent to dopaminergic neurons of the Pink1(-", -) mouse model of Parkinson’s disease, 2016, pp.10, 168~
- Kitada T, "Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice", Proc Natl Acad Sci U S A, 104, pp.11441~11446 (2007)
- Feligioni M, "Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice", Synapse, 70, pp.223~230 (2016)
- Martella G, "Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice", Neurobiol Dis, 91, pp.21~36 (2016)
- Morais VA, "Parkinson’s disease mutations in PINK1 result in decreased complex I activity and deficient synaptic function", EMBO Mol Med, 1, pp.99~111 (2009)
- Usami Y, "DJ-1 associates with synaptic membranes", Neurobiol Dis, 43, pp.651~662 (2011)
- Kyung JW, "DJ-1deficiency impairs synaptic vesicle endocytosis and reavailability at nerve terminals", Proc Natl Acad Sci U S A, 115, pp.1629~1634 (2018)
- Ishikawa S, "Stimulation of vesicular monoamine transporter 2 activity by DJ-1 in SH-SY5Y cells", Biochem Biophys Res Commun, 421, pp.813~818 (2012)
- Wang Y, "DJ-1 is essential for long-term depression at hippocampal CA1 synapses", Neuromolecular Med, 10, pp.40~45 (2008)
- Krebs CE, "The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures", Hum Mutat, 34, pp.1200~1207 (2013)
- Quadri M, "Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism", Hum Mutat, 34, pp.1208~1215 (2013)
- Kirola L, "Identification of a novel homozygous mutation Arg459Pro in SYNJ1 gene of an Indian family with autosomal recessive juvenile Parkinsonism", Parkinsonism Relat Disord, 31, pp.124~128 (2016)
- Chen KH, "Mutational analysis of SYNJ1 gene (PARK20) in Parkinson’s disease in a Taiwanese population", Neurobiol Aging, 36, pp.2905.e7~2905.e8 (2015)
- Vanhauwaert R, "The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals", EMBO J, 36, pp.1392~1411 (2017)
- Deng HX, "Identification of TMEM230 mutations in familial Parkinson’s disease", Nat Genet, 48, pp.733~739 (2016)
- Kim MJ, "The Parkinson’s disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking", Hum Mol Genet, 26, pp.729~741 (2017)
